PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
Encyclopedia of Signaling Molecules10.1007/978-3-319-67199-4_10200820182777-2777Krebs von den Lungen-6 (KL-6)http://link.springer.com/content/pdf/10.1007/978-3-319-67199-4_102008
Clinical & Experimental Allergy10.1111/cea.13744202050121391-1399Krebs von den Lungen‐6 (KL‐6) is a pathophysiological biomarker of early‐stage acute hypersensitivity pneumonitis among pigeon fanciersYuan Ji, Stephen J. Bourke, Mark Spears, Louise V. Wain, Gavin Boyd, Phillip P. Lynch, Matthew Cunningham, Kenneth Boyd, Iona Donnelly, Nobuoki Kohno, Charles McSharryhttps://onlinelibrary.wiley.com/doi/pdf/10.1111/cea.13744, https://onlinelibrary.wiley.com/doi/full-xml/10.1111/cea.13744, https://onlinelibrary.wiley.com/doi/pdf/10.1111/cea.13744
British Journal of Dermatology10.1111/bjd.16993201817961396-1397Secukinumab decreases serum Krebs von den Lungen 6 (KL-6) level in patients with psoriasis with elevated serum KL-6 levelC. Chijiwa, S. Takeoka, M. Kamata, H. Uchida, S. Fukaya, K. Hayashi, A. Fukuyasu, T. Tanaka, T. Ishikawa, T. Ohnishi, Y. Tadahttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fbjd.16993, http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjd.16993/fullpdf
Diabetes10.2337/db19-151-lb201968Supplement 1151-LB151-LB: High Risk of Krebs Von Den Lungen-6 (kL-6) Elevation when Dipeptidyl Peptidase-4 Inhibitors and Amiodarone Are Prescribed SimultaneouslyJUNICHI OKADA, SHUICHI OKADA, MASANOBU YAMADAhttps://syndication.highwire.org/content/doi/10.2337/db19-151-LB
The Egyptian Journal of Bronchology10.1186/s43168-020-00043-w2020141Serum Krebs von den Lungen (KL-6) level as a marker of exacerbation of interstitial lung diseasesZainab H. Saeed, Mohammed H. Magdy, Emad A. Abdelnaem, Madyan M. Mahmoudhttp://link.springer.com/content/pdf/10.1186/s43168-020-00043-w.pdf, http://link.springer.com/article/10.1186/s43168-020-00043-w/fulltext.html, http://link.springer.com/content/pdf/10.1186/s43168-020-00043-w.pdf
PLOS ONE10.1371/journal.pone.02496072021164e0249607Krebs von den Lungen 6 (KL-6) as a marker for disease severity and persistent radiological abnormalities following COVID-19 infection at 12 weeksDavid T. Arnold, Charmaine Donald, Max Lyon, Fergus W. Hamilton, Anna J. Morley, Marie Attwood, Alexandra Dipper, Shaney L. Barratthttps://dx.plos.org/10.1371/journal.pone.0249607
La Revue de Médecine Interne10.1016/j.revmed.2018.03.292201839A67Krebs von den Lungen-6 (KL-6), un marqueur de fibrose pulmonaire et de sévérité dans la sclérodermie systémiqueA. Benyamine, X. Heim, N. Resseguier, D. Bertin, C. Gomez, M. Ebbo, J.R. Harlé, G. Kaplanski, P. Rossi, N. Bardin, B. Granelhttps://api.elsevier.com/content/article/PII:S0248866318303904?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0248866318303904?httpAccept=text/plain
International Journal of Cancer10.1002/ijc.2600720111302377-387Krebs von den Lungen-6 (KL-6) is a prognostic biomarker in patients with surgically resected nonsmall cell lung cancerSonosuke Tanaka, Noboru Hattori, Nobuhisa Ishikawa, Hiroyasu Shoda, Atsushi Takano, Ryohei Nishino, Morihito Okada, Koji Arihiro, Kouki Inai, Hironobu Hamada, Akihito Yokoyama, Nobuoki Kohnohttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fijc.26007
Journal of Diabetes10.1111/1753-0407.12852201811195-96Metformin administration attenuates dipeptidyl peptidase-4 inhibitor-induced increases in Krebs von den Lungen-6 (KL-6) levelsJunichi Okada, Eijiro Yamada, Yawara Niijima, Shuichi Okada, Masanobu Yamadahttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2F1753-0407.12852, http://onlinelibrary.wiley.com/wol1/doi/10.1111/1753-0407.12852/fullpdf
Rheumatology10.1093/rheumatology/key42020195861034-1039Usefulness of serum Krebs von den Lungen-6 for the management of myositis-associated interstitial lung diseaseSatoshi Takanashi, Naoshi Nishina, Maho Nakazawa, Yuko Kaneko, Tsutomu Takeuchihttp://academic.oup.com/rheumatology/article-pdf/58/6/1034/28697397/key420.pdf